Back to Search Results
Jeffrey Jones
Schedule an appointment (614) 293-3196
Insurances We Accept
I’m an oncologist treating patients with leukemia and other blood cancers. I have a special focus on chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma. I'm honored to work among the internationally renowned physicians at OSUCCC – James, where we provide state-of-the-art patient care. In 2014, I was rated in the top 10 percent of physicians in the nation for patient satisfaction.

Research plays a significant role in my career. My research team conducts experimental therapies and drug trials to improve treatments for CLL and other lymphoid malignancies. Our findings were used to develop Ibrutinib, a drug recently approved by the FDA to treat CLL patients.

I'm passionate about spreading knowledge to others in my field through lectureships, medical publications and student advising. In 2014, I was rated in the top 10 percent of physicians in the nation for patient satisfaction. I've also been recognized as an outstanding faculty educator at OSU.

At The James, we continue to transform the way cancers are prevented, detected and treated. I believe our unyielding desire to find answers will one day lead to a cure.

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014

Medical Degree

  • M.D.
    University of Michigan Medical School
    6/9/2000

Residency

  • Internal Medicine
    McGill University
    7/1/2001 - 6/30/2003

Additional languages I speak

  • French

Specialties and conditions I treat

  • Hematology
  • Chronic Lymphocytic Leukemias
  • Leukemia, Lymphoid
  • Non-Hodgkin Lymphoma
  • Hairy Cell Leukemia
  • Blood Cancers

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

More about my work

My background

Fellowship

  • Hematology/Oncology
    University of Texas Anderson Cancer Center
    7/1/2003 - 6/30/2006

Board Certifications

American Board of Internal Medicine
8/19/2003

American Board of Internal Medicine (Subspecialty: Hematology)
10/27/2006

American Board of Internal Medicine (Subspecialty: Medicine Oncology)
11/13/2007

My Department

Internal Medicine

My Division

Hematology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/17, Dr. Jones has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.

  • AbbVie Pharmaceuticals
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Pharmacyclics, Inc.
  • Genentech